HIGHLIGHTS
- who: MAOI and collaborators from the PsychoTropical Research, QLD, Australia, Department of Psychiatry, University of Toronto, Toronto, ON, Canada have published the Article: The prescriber s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression, in the Journal: (JOURNAL) of 06/05/2022
- what: Several clinician members of the Workgroup wish, therefore, to reiterate the purpose of this document: it is a guide, not a rulebook. The aim of this Prescriber`s guide is to provide a practical resource to support practicing physicians in confidently implementing MAOIs into their antidepressant armamentarium, and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.